Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
JCO Global Oncology
|
March 17, 2026
Unfinished Frock
Praveen Kumar Marimuthu
BMJ Supportive & Palliative Care
|
June 27, 2025
Early palliative care integration in advanced cancer: two institutional quality improvement projects
Meenakshi V Venketeswaran, Jewell Joseph, Shanthi Prasoona Thotampuri, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 15, 2021
Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India
Govindaraj Ganesan, Sasipriya Ponniah, Vivek Sundaram, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 13, 2021
Response to comments on "Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India"
Govindaraj Ganesan, Sasipriya Ponniah, Vivek Sundaram, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 27, 2021
Whole lung irradiation as a novel treatment for COVID-19: Final results of the prospective randomized trial (WINCOVID trial)
Govindaraj Ganesan, Sasipriya Ponniah, Vivek Sundaram, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 14, 2022
Response to "Comments on whole lung irradiation as a novel treatment for COVID-19: Final results of the prospective randomized trial (WINCOVID trial)"
Govindaraj Ganesan, Sasipriya Ponniah, Vivek Sundaram, et al.
Scientific Reports
|
October 8, 2025
Low-dose nivolumab plus induction chemotherapy for locally advanced or unresectable head and neck cancer is associated with high response rates and conversion to definitive therapy
Josh Thomas Georgy, Soumya Susan Regi, Rosh Varghese Georgy, et al.
JCO Global Oncology
|
March 24, 2025
Real-World Outcomes of Induction Chemotherapy With or Without Low-Dose Nivolumab for Stage III Non-Small Cell Lung Cancer Ineligible for Up-Front Local Therapy: A Propensity Score-Matched Analysis
Praveen Kumar Marimuthu, Josh Thomas Georgy, Deepa Susan Joy Philip, et al.
The Lancet Regional Health. Southeast Asia
|
March 11, 2026
Low-dose nivolumab with neoadjuvant chemotherapy and oral metronomic therapy in borderline resectable oral cavity squamous cell carcinoma: a phase II trial
Praveen Kumar Marimuthu, Chitra Renukaradhya, Shalini Sahu, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
JCO Global Oncology
|
March 17, 2026
Unfinished Frock
Praveen Kumar Marimuthu
BMJ Supportive & Palliative Care
|
June 27, 2025
Early palliative care integration in advanced cancer: two institutional quality improvement projects
Meenakshi V Venketeswaran, Jewell Joseph, Shanthi Prasoona Thotampuri, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 15, 2021
Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India
Govindaraj Ganesan, Sasipriya Ponniah, Vivek Sundaram, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 13, 2021
Response to comments on "Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India"
Govindaraj Ganesan, Sasipriya Ponniah, Vivek Sundaram, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 27, 2021
Whole lung irradiation as a novel treatment for COVID-19: Final results of the prospective randomized trial (WINCOVID trial)
Govindaraj Ganesan, Sasipriya Ponniah, Vivek Sundaram, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 14, 2022
Response to "Comments on whole lung irradiation as a novel treatment for COVID-19: Final results of the prospective randomized trial (WINCOVID trial)"
Govindaraj Ganesan, Sasipriya Ponniah, Vivek Sundaram, et al.
Scientific Reports
|
October 8, 2025
Low-dose nivolumab plus induction chemotherapy for locally advanced or unresectable head and neck cancer is associated with high response rates and conversion to definitive therapy
Josh Thomas Georgy, Soumya Susan Regi, Rosh Varghese Georgy, et al.
JCO Global Oncology
|
March 24, 2025
Real-World Outcomes of Induction Chemotherapy With or Without Low-Dose Nivolumab for Stage III Non-Small Cell Lung Cancer Ineligible for Up-Front Local Therapy: A Propensity Score-Matched Analysis
Praveen Kumar Marimuthu, Josh Thomas Georgy, Deepa Susan Joy Philip, et al.
The Lancet Regional Health. Southeast Asia
|
March 11, 2026
Low-dose nivolumab with neoadjuvant chemotherapy and oral metronomic therapy in borderline resectable oral cavity squamous cell carcinoma: a phase II trial
Praveen Kumar Marimuthu, Chitra Renukaradhya, Shalini Sahu, et al.
Page
of 1